Tofacitinib
- PDF / 169,005 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 70 Downloads / 163 Views
1
Tofacitinib Blue finger syndrome: case report. In a retrospective study, involving 144 patients, one patient [age and sex not stated] was described, who developed blue finger syndrome while being treated with tofacitinib. The patient with rheumatoid arthritis was initiated on oral tofacitinib 5mg twice daily. After 10 days of tofacitinib treatment, the patient developed blue finger syndrome. The therapy of tofacitinib was stopped thereafter. Author comment: "The safety profile was comparable to published data, except for a single case of blue finger syndrome." Mueller RB, et al. Effectiveness, tolerability, and safety of tofacitinib in rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen and Aarau Cohorts. Journal of Clinical Medicine 8: 1548, No. 10, 2019. Available 803440091 from: URL: http://doi.org/10.3390/jcm8101548 - Switzerland
0114-9954/19/1784-0001/$14.95 Adis © 2019 Springer Nature Switzerland AG. All rights reserved
Reactions 21 Dec 2019 No. 1784
Data Loading...
